Pablo Hendler to Speak at The Knowledge Group’s Paragraph IV Patent Protection and Litigation: Addressing the Complex Challenges LIVE Webcast
The Knowledge Group/The Knowledge Congress Live Webcast Series, the leading producer of regulatory focused webcasts, has announced today that Pablo Hendler will speak at a webcast entitled: “Paragraph IV Patent Protection and Litigation: Addressing the Complex Challenges” This event is scheduled for Tuesday, October 3, 2019 from 3:00 pm to 4:00 pm ET.
- (1888PressRelease) September 25, 2019 - For further details, please visit: https://www.theknowledgegroup.org/webcasts/paragraph-iv-patent-protection-and-litigation/
About Pablo Hendler
Pablo Hendler has counseled clients for nearly 25 years in intellectual property matters. Focusing his practice on life science patent litigation, he is well-equipped to counsel clients in pharmaceutical, biotechnology, and medical device litigation. Specifically, Pablo has served as lead counsel, in both the Federal Courts and the Patent Trial and Appeal Board. His extensive litigation experience, and his background as a researcher and inventor, has served him well in counseling clients on how to successfully cross the intersection of FDA and patent law.
Pablo's clients have consistently praised him as an "excellent lawyer" and for his "sterling" work in ANDA litigations. They are comforted by his "seen-and-done-it-all experience" who “blends deep patent law and regulatory knowledge.”
Pablo has written and spoken on a broad range of patent-related topics, particularly in the area of Hatch Waxman litigation.
Abstract
Protecting pharmaceutical patents in today’s business landscape is even made more challenging by the growing number of threats and risks. One of the crucial weak spots for drug companies aiming to guard their patents is the Abbreviated New Drug Application (ANDA) process, particularly Paragraph IV (PIV) certification. It is already becoming common for brand companies to receive a PIV challenge from a generic company.
The increasing PIV filings require both patent holders and challengers to be equipped with up-to-date knowledge of addressing complex challenges surrounding patent protection and PIV disputes.
In this LIVE Webcast, a seasoned panel of thought leaders and professionals brought together by The Knowledge Group will provide insights on how to manage the complex challenges that both brand name and generic drug manufacturers face. The speakers will present the recent patent infringement cases that have significant implications on the current legal setting. They will also offer the best practices in protecting patents and litigating PIV effectively.
This LIVE Webcast will discuss the following key provisions:
- Patent Protection – Recent Trends
- Notable Paragraph IV Cases
- Double Patenting and Patent Term Adjustment
- Best Patent Protection Practices
- Practical Litigation Tips
- Outlook
About The Knowledge Group
The Knowledge Group was established with the mission to produce unbiased, objective, and educational live webinars that examine industry trends and regulatory changes from a variety of different perspectives. The goal is to deliver a unique multilevel analysis of an important issue affecting business in a highly focused format. To contact or register to an event, please visit: http://theknowledgegroup.org/.
###
space
space